全球乳房切片市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，乳房切片市場規模將從 2025 年的 8.7 億美元成長至 14 億美元，2026 年至 2034 年的複合年成長率為 5.33%。

隨著全球乳癌病例的增加，全球乳房切片市場也穩定成長。人們對早期癌症檢測和定期篩檢計畫的意識提升是推動市場擴張的主要動力。政府和醫療機構推廣乳房X光檢查和診斷測試，直接增加了對切片檢查的需求。微創切片檢查技術和影像引導系統等技術的進步也提高了活體組織切片的安全性和準確性，鼓勵更多患者選擇早期診斷。

推動該市場成長的主要因素包括老年人女性人口的成長、生活方式相關的風險因素以及開發中國家醫療基礎設施的改善。由於疼痛減輕和恢復時間縮短，真空抽吸活體組織切片和空芯針切片檢查等先進切片檢查設備正變得越來越普及。醫院和診斷中心正在投資更好的影像技術以提高檢測準確性。此外，已開發地區優惠的報銷政策也為患者獲得這些檢查提供了支持。

展望未來，人工智慧 (AI) 和數位成像解決方案的融合預計將推動市場強勁成長。 AI 影像分析將幫助醫生更準確、更快速地檢測異常情況。在新興經濟體，不斷提高的健康意識和醫療費用支出的成長可能會創造新的成長機會。對微創和快速診斷方法的持續研究將在未來幾年進一步推動市場需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球乳房切片市場：依產品分類

• 市場分析、洞察與預測
• 真空抽吸切片檢查
• 核心針穿刺切片
• 細針穿刺切片檢查

第5章：全球乳房切片市場：依影像導引技術分類

• 市場分析、洞察與預測
• 磁振造影引導下乳房切片
• 超音波引導下乳房切片
• 乳房X光引導立體定位切片檢查
• CT引導下切片檢查
• 其他影像引導乳房切片

第6章 全球乳房切片市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷中心

第7章 全球乳房切片市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Ethicon Endo Surgery
  • Cook Medical Incorporated
  • Galini SRL
  • Hologic Inc
  • CR Bard Inc
  • Intact Medical Corporation
  • Becton And Dickinson Company
  • Argon Medical Devices
  • Encapsule Medical Devices LLC
  • Leica Biosystems Nussloch GmbH

The Breast Biopsy Market size is expected to reach USD 1.40 Billion in 2034 from USD 0.87 Billion (2025) growing at a CAGR of 5.33% during 2026-2034.

The Global Breast Biopsy Market is growing steadily due to the rising number of breast cancer cases worldwide. Increasing awareness about early cancer detection and regular screening programs is supporting market expansion. Governments and healthcare organizations are promoting mammography and diagnostic tests, which directly increases the demand for biopsy procedures. Technological advancements such as minimally invasive biopsy techniques and image-guided systems are also making procedures safer and more accurate, encouraging more patients to opt for early diagnosis.

The main drivers of this market include the growing female population in aging groups, lifestyle-related risk factors, and improved healthcare infrastructure in developing countries. Advanced biopsy devices like vacuum-assisted and core needle biopsy systems are gaining popularity because they reduce pain and recovery time. Hospitals and diagnostic centers are investing in better imaging technologies to improve detection accuracy. In addition, favorable reimbursement policies in developed regions are supporting patient access to these procedures.

Looking ahead, the market is expected to witness strong growth with the integration of artificial intelligence and digital imaging solutions. AI-powered imaging analysis can help doctors detect abnormalities more accurately and quickly. Emerging economies are likely to offer new growth opportunities as awareness and healthcare spending increase. Continuous research in less invasive and faster diagnostic methods will further boost market demand over the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Vacuum Assisted Biopsy
• Core Needle Biopsy
• Fine Needle Aspiration Biopsy

By Image Guided Technology

• MRI Guided Breast Biopsy
• Ultrasound Guided Breast Biopsy
• Mammography Guided Stereotactic Biopsy
• CT Guided Biopsy
• Other Image Guided Breast Biopsy

By End User

• Hospitals and Clinics
• Diagnostic Centers

COMPANIES PROFILED

• Ethicon Endo Surgery, Cook Medical Incorporated, Galini SRL, Hologic Inc, C R Bard Inc, Intact Medical Corporation, Becton and Dickinson Company, Argon Medical Devices, Encapsule medical Devices LLC, Leica Biosystems Nussloch GmbH
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BREAST BIOPSY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Vacuum Assisted Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Core Needle Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fine Needle Aspiration Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BREAST BIOPSY MARKET: BY IMAGE GUIDED TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Image Guided Technology
• 5.2. MRI Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ultrasound Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Mammography Guided Stereotactic Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CT Guided Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Image Guided Breast Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BREAST BIOPSY MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BREAST BIOPSY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Image Guided Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Image Guided Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Image Guided Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Image Guided Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Image Guided Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BREAST BIOPSY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Ethicon Endo Surgery
  • 9.2.2 Cook Medical Incorporated
  • 9.2.3 Galini SRL
  • 9.2.4 Hologic Inc
  • 9.2.5 C. R. Bard Inc
  • 9.2.6 Intact Medical Corporation
  • 9.2.7 Becton And Dickinson Company
  • 9.2.8 Argon Medical Devices
  • 9.2.9 Encapsule Medical Devices LLC
  • 9.2.10 Leica Biosystems Nussloch GmbH